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Abstract
This chapter summarizes recent research on the biology of reactive oxygen species (ROS). 
The chapter is focused on the bimodal actions of ROS, which can be summarized as both 
beneficial and negative. The beneficial aspects of ROS are related to their effects on the 
redox state of cells and the important role that some ROS play in signaling cascade. The 
detrimental effects of ROS are related excess amounts of these chemical moieties, which 
are caused by excessive production and/or insufficient actions of endogenous antioxi-
dants. The generation of these species is also discussed.
Keywords: reactive oxygen species, oxidative stress, superoxide
1. Introduction
Reactive oxygen species (ROS) are defined as chemically reactive oxygen radicals as well as 
non-radical derivatives of oxygen [1]. The varying range of reactivity each reactive oxygen 
species exhibits is crucial to its impact at the molecular level. Their significance in the devel-
opment of many cardiovascular diseases is well known, but they also have beneficial roles in 
cells. Developing a balance between the overproduction of ROS and its utilization is impor-
tant in maintaining healthy redox processes within the cells.
2. Generation of reactive oxygen species
The main types of reactive oxygen species discussed in this paper are superoxide and hydro-
gen peroxide, both of which play a large role in cardiovascular diseases. Additionally, the 
production of hydroxyl radicals and singlet oxygen will be mentioned, as these are the most 
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reactive, and subsequently dangerous, of the ROS. Lastly the generation of peroxynitrite will 
be considered. See Table 1 for an overview of the mechanism of generation for each.
Superoxide is produced by the one-electron reduction of molecular oxygen. Superoxide is 
then converted to hydrogen peroxide via the mitochondrial enzyme superoxide dismutase 
(MnSOD), or into diatomic oxygen [2]. Hydrogen peroxide itself is fairly unreactive, but plays 
a role in the Fenton reaction to generate hydroxyl radicals that can be damaging to cellular 
structures and molecules. Haber and Weiss demonstrated in 1934 that a superoxide molecule 
and a hydrogen peroxide molecule could interact with each other to produce these reactive 
hydroxyl radicals in the following net reaction: •O
2
− + H
2
O
2
 → •OH + OH− + O
2
 [3]. Hydroxyl 
radicals can also be formed from reactions with hypochlorous acid, which is produced by 
the enzyme myeloperoxidase [4]. The production of hydroxyl radicals in tissue is significant 
for its contribution to a variety of pathologies, but also for the fact that it cannot be removed 
enzymatically in the same way that superoxide is converted back to oxygen via SOD.
There are many enzymatic pathways by which ROS can be generated in the cell. Most path-
ways involve the initial production of superoxide, which, as previously indicated, lead to 
the production of even more reactive compounds. Although some enzymatic systems “inten-
tionally” generate superoxide, e.g., NADPH oxidases, this ROS is also a consequence of 
metabolism. Specifically, in aerobic cellular respiration, superoxide is a byproduct of oxygen 
utilization. The electron transport chain (ETC) of the mitochondria is a major source its gen-
eration. The ETC is made up of three complexes and an ATP synthase enzyme; it functions by 
transferring electrons through a series of electron carriers. The transfer of electrons is coupled 
with the release of protons into the intermembrane space of the mitochondria, creating an 
electrochemical potential, ∆p, across the inner membrane, which drives the production of 
ATP [5]. However, when electrons are leaked from the complexes, instead of being trans-
ferred, these leaked species are those that reduce oxygen to form superoxide.
The first complex in the ETC is composed of a flavin mononucleotide group and is a signifi-
cant site of production of superoxides. The donation of electrons is initially provided to the 
chain by NADH to the FMN, which subsequently passes them along a chain of FeS to the 
reduction site CoQ [6]. Superoxide is produced when FMN is fully reduced; its degree of 
reduction has been shown to be dependent on the ratio of NADH/NAD+, with the proportion 
Reactive oxygen species Mechanism of generation
Superoxide (O−
2
) Reduction of molecular oxygen in the electron transport chain of mitochondria [4, 6], and 
other enzymatic routes: monooxygenase, NADPH oxidase, xanthine oxidase [8, 10]
Hydrogen peroxide 
(H
2
O
2
)
Converted from O−
2
 by enzyme superoxide dismutase (SOD) [18]
Hydroxyl radical (•OH) Produced in Haber-Weiss reaction from O−
2
 and H
2
O
2
 [2]
Singlet oxygen (1O
2
) Produced in reaction of hypochlorous acid (HOCl) and H
2
O
2
 [3]
Peroxynitrite (ONOO−) Produced in reaction of nitric oxide (NO) and (O−
2
) [15]
Table 1. Production of reactive oxygen species.
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of FMNs reduced correlating to a higher ratio [7]. This has been confirmed with the experi-
mental addition of rotenone, a complex I inhibitor; its function is to limit the transfer of elec-
trons away from complex I, creating a condition where they are “backed up” onto the NADH 
and are available for superoxide generation [7].
The third complex in the ETC is also a significant site of superoxide generation. Complex III 
is where electrons are transferred from CoQ to the cytochrome c. Changes in the ∆p or in the 
reduction state of CoQ are contributors to the production of superoxide at Complex III, as 
well as the addition of the inhibitor antimycin [5]. Compared to complex I, the superoxide 
generation at this site is less significant.
Outside of the ETC, ROS can be generated in the mitochondria by different means. In the 
event that complex I is inhibited, and 2-oxoglutarate is added as a substrate, there is still 
a high level of superoxide generated by the enzyme α-ketoglutarate dehydrogenase, which 
also contains a flavin subunit and utilizes the reduced NADH pool of electrons that complex 
I is unable to use [8]. Cytochrome P450 is another enzyme within the mitochondria that has 
been implicated in ROS production. Its regular function involves complex reactions convert-
ing cholesterols and other steps in steroid biosynthesis; it catalyzes monooxygenase reactions 
that require electrons from NADPH, which can “leak” and interact with diatomic oxygen to 
produce superoxides [9]. These are just two examples of a variety of mitochondrial reactions 
involving the utilization of electrons that produces ROS at this organelle.
Mitochondrial respiration is not the only source of ROS generation. Other sources of ROS pro-
duction include the processes of the enzymes nicotinamide adenine dinucleotide phosphate 
oxidase (NADPH oxidase), xanthine oxidoreductase, and myeloperoxidase [10].
NADPH oxidase functions as a multi-subunit enzyme which, via electrons donated by 
NADPH, can reduce oxygen to superoxide. NADPH oxidase is well known in leukocytes, 
but also exists in other tissues in different forms, such as in vascular smooth muscle. The 
leukocyte NADPH oxidase is primarily found in polymorph-nuclear neutrophils, or PMNs, 
and its function is the generation and subsequent release of superoxide as a mechanism for 
combating bacterial infection. The vascular NADPH oxidase is mainly activated by angioten-
sin II, but also thrombin, platelet-derived growth factor (PDGF), vascular endothelial growth 
factor (VEGF), tumor necrosis factor-alpha (TNF-alpha), and other mechanical stimuli such 
as shear stress and strain [11]. Its function in these cells correlates to the development of car-
diovascular disease, but also the dismuatation of superoxide results in the production of the 
vasodilator, H
2
O
2
 [12].
Xanthine oxidoreductase has two interconvertible forms as an enzyme, both of which are 
essential to purine catabolism by oxidizing hypoxanthine to xanthine to uric acid. Its dehy-
drogenase oxidizes NADH to NAD, while in its oxidase form, the enzyme is capable of pro-
ducing both superoxide and hydrogen peroxide from diatomic oxygen [13].
Myeloperoxidase is highly significant not for the production of superoxides but because 
hypochlorous acid is its main product [14]. HOCl is a key intermediate for the generation of 
many different ROS and is, in itself, highly reactive—it can react with superoxides to pro-
duce hydroxyl radicals, or with hydrogen peroxide to produce a singlet oxygen [4]. Singlet 
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oxygens are extremely reactive species. Hypochlorous acid itself is implicated in various cel-
lular reactions as well, such as initiating lipid peroxidation, or oxidizing protein sulfhydryl 
and thioether groups on proteins [4, 15, 16].
Nitric oxide, which is in the family reactive nitrogen species, plays a significant role in vascu-
lar tone in the circulatory system. While its generation is not discussed here, it is important 
to mention because it greatly increases in toxicity when it reacts with superoxide to gener-
ate peroxynitrite (ONOO─), a powerful oxidant [17]. Peroxynitrite itself reacts slowly, giv-
ing it selective reactivity within the cell, giving it wide implications for cellular pathology 
[18]. Despite its high reactivity, it is highly stable with a negative charge delocalized over the 
whole molecule, providing the ability to be a highly influential oxidant. Table 1 summarizes 
the generation of reactive oxygen species.
3. The “good side” of ROS
Reactive oxygen species (ROS) have been given a considerable amount of scrutiny due to 
the disease states that they have been linked to, such as aging, cancer, and atherosclerosis 
[19]. However, ROS is imperative for redox homeostasis, as well as proper function in the 
cardiovascular system, and immune system. The body requires a balance in its ROS levels for 
homeostasis. If the level of ROS exceeds that which the body can handle, then oxidative stress 
occurs [20]. On the other hand, if the level is too low, reductive stresses occur and can also 
cause pathologies ranging from cancer to cardiomyopathy [21].
Redox regulation is imperative for the body to maintain proper signaling processes. These 
redox reactions usually entail ROS interacting with the amino acid cysteine on proteins. ROS 
modulates cell proliferation and apoptotic pathways to ensure proper regulation of the cell 
cycle and programmed cell death. There are multiple kinases in these pathways that interact 
with ROS. The mitogen- activated protein kinase (MAPK) has a MAPKKK upstream called 
apoptosis signal regulated kinase 1 (ASK1). ASK1 regulates transcription factors JNK and 
p38, which can trigger apoptosis by phosphorylating MAPKK4,3, and cGMP dependent pro-
tein kinase (PKG) and protein kinase A (PKA) are both activated by ROS as well and are 
involved in the MAPK signaling process. ROS can also inhibit protein phosphatases through 
cysteine oxidation that prevents the inhibitory actions of the phosphatase on MAPK signal-
ing. Consequently, transcription factors such as p38 can be regulated this way as well. Protein 
tyrosine phosphatase (PTP) is oxidized and inhibited by ROS and helps maintain appropriate 
levels of growth factor signals. Tyrosine phosphatases are affected by ROS in a manner con-
sistent with our concept of the redox window. Physiological levels of H
2
O
2
 will activate tyro-
sine kinases through cysteine oxidation to sulfenic acid; however, high levels of ROS oxidize 
cysteine into sulfinic and sulfonic acids which lead to complete inactivation of the phospha-
tase through irreversible modification of the catalytic cysteine [22]. Another major signaling 
pathway, phosphoinositide 3-kinase (PI3K), is regulated by ROS through oxidation reactions. 
The body maintains a homeostatic level of ROS because ROS products activate antioxidant 
genes through mechanisms such as PI3K-NFE2-like2 (Nrf2)-antioxidant response element 
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(ARE) [23]. Ref-1, also known as redox factor-1, is an endonuclease that is regulated through 
transcription factors such as activator protein 1 (AP-1), p53, nuclear factor kappa B (NFkB) 
and hypoxia inducible factor 1 (HIF-alpha). When cytoplasmic Ref-1 is subjected to oxidative 
stress, by exposure to ROS, it moves to the nucleus and helps the redox factor interact with 
transcription factors so an antioxidant defense system can be initiated [23].
Many of these redox regulatory pathways are evident when examining the impact of ROS 
on collateral blood vessel growth, which is a major area of interest in all forms of vascular 
disease, e.g., peripheral artery disease, ischemic heart disease. A conundrum about the role of 
ROS in coronary collateral growth pertains to observations that too much ROS, and the con-
current oxidative stress, inhibits collateral growth. On the opposite side of the spectrum, too 
little ROS and the consequential reductive stress, also inhibits coronary collateral growth. This 
optimal “level” of ROS has been dubbed “redox window” [24], which is the level of the redox 
state that is optimal for growth factor signaling. p53 is thought to be the connection between 
redox dependent and growth factor dependent signaling. Angiogenesis is mediated through 
a transcription factors, such as nuclear factor kappaB, and ROS such as H
2
O
2
, NO and other 
oxidants
7
. H
2
O
2
 is a major mediator of HIF-1a [25], a major transcription factor required for 
vascularization in ischemic settings [26]. Vascular endothelial growth factor (VEGF) activates 
NADPH oxidase to produce ROS. ROS produced through this process works in conjunction 
with VEGF to trigger endothelial cell migration and proliferation. Vascular NADPH oxidase, 
a generator of ROS, is also triggered by angiotensin II (Ang II), which is a key component 
of angiogenesis. The necessity of ROS to appropriately activate angiogenesis is yet another 
exemplification of the beneficial use of ROS in the body [27]. The thyroid hormone can acti-
vate angiogenesis by triggering transcription factors such as VEGF and HIF-1a [28]. Both of 
which were described above as producers of ROS that further propagate the angiogenesis 
process.
Vascular smooth muscle cells require ROS for appropriate cell growth [29]. PDGF and throm-
bin are both agonists to help cell proliferation, and both agonists require ROS in their mech-
anisms to amplify and further their signal for greater cell growth [30]. ROS also plays an 
important role in the expression of transcription nuclear factor-kB, which helps the body’s 
inflammatory process by activating the monocyte chemotactic protein-1 (MCP-1) and inter-
leukin-6 [31]. Many reactive oxygen species, such as H
2
O
2
, play a big part in vasomotor tone 
such as vasorelaxation in the pulmonary, coronary and mesenteric systems [32].
Reactive oxygen species has an important role in the immune system. A lack of ROS in the 
immune system can cause disease states that impair an individual’s ability to fight against 
foreign invasion. The innate immunity that utilizes macrophages, neutrophils, and dendritic 
cells are key. These cells use toll like receptors to determine a cell that is foreign to the body, 
such as a bacterium. As a part of the innate immune system, macrophages, neutrophils and 
dendritic cells can phagocytose foreign material and then express it to the acquired immune 
system. The phagocytosis process is made possible by the use of reactive oxygen species. 
As previously mentioned, the ROS used in this process is made on the endosomes of the 
phagocytosing cells using NADPH oxidase. The immune system ensures the production of 
ROS when a foreign substance is detected due to the toll like receptor-4 binding to NADPH 
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oxidase. Such makes certain that when a foreign substance is detected in the body and it binds 
to the toll like receptor-4, the NADPH oxidase is consequently triggered to make sure there is 
ROS production to breakdown the foreign entity [31].
Nitric oxide a reactive nitrogen species that easily diffuses across most tissues, but has a diffi-
cult time being carried through blood because oxyhemoglobin breaks it down. However, due 
to its rapid diffusion rates, it reacts with superoxide with diffusion limited kinetics, resulting 
in the formation of the potent oxidant, peroxynitrite. Although by convention peroxynitrite 
is viewed as deleterious [17], it is noteworthy to add that this species is used by the immune 
system destroy bacteria. Macrophages produce peroxynitrite, and this mechanism was found 
to kill amounts of Escherichia coli in proportion to the amount of peroxynitrite produced in the 
macrophage [33].
When ROS production is not appropriate, many disease states can occur. Chronic granuloma-
tous disease (CGD) is a rare hereditary disease where there is a defect in the NADPH oxidase. 
As a result, infections such as pneumonia and osteomyelitis can occur. Since the body cannot 
fight the infection, it creates granulomas around the infections. The treatment for the disease 
is designed to help the immune system through antibacterial, antifungal and immunomodu-
latory therapy. Stem cell transplants and gene therapy are both definitive treatments used as 
the first clinical interventions [34].
All some reactive oxygen species such as superoxide and hydrogen peroxide have beneficial 
effects (at physiological levels), some reactive oxygen species, such as the hydroxyl radical, 
react and form bonds with almost all organic molecules in the body. As a result, this particular 
species is exclusively deleterious when produced within a cell. When the ROS levels deviate 
away from the “redox widow,” imbalance in these systems occurs and detrimental conse-
quences can be triggered [24].
However, while redox homeostasis of ROS is imperative for normal bodily function ranging 
from an effective immune system to angiogenesis, an imbalance in said homeostasis is not 
always terrible. When the body experiences acute trauma such as a hemorrhage, the renin-
angiotensin system comes into play [35]. Angiotensin II helps constrict the blood vessels to 
increase the blood pressure that considerably drops due to the loss of blood [36]. Angiotensin 
II activates NADPH oxidase in smooth muscle cells causing a production of superoxides [37]. 
The superoxides partake in the angiotensin II mechanisms. However simultaneously there 
is a decrease in the nitric oxide present in the blood because NO scavengers, such as NOX, 
actively eliminate them [38]. By increasing the levels of superoxides and decreasing the lev-
els of NO, vasodilation is minimized and platelet coagulation is much more effective [39]. A 
hemorrhage is a wonderful example of how the body naturally handles crises by tipping the 
redox homeostatic scale toward a greater production of superoxides.
4. The “bad side” of ROS
The production of mitochondrial reactive oxygen species (ROS) is found in both physiologi-
cal and pathological conditions. When ROS production increases above basal level, however, 
Reactive Oxygen Species (ROS) in Living Cells12
the excessive amounts of ROS can lead to pathologies ranging from autoimmune diseases 
to cardiomyopathies. As mentioned previously, there are numerous sources of ROS in a cell 
that may occur in cytosolic, extracellular, and mitochondrial domains. The relative amounts 
of mitochondrial ROS produced are indicative of the metabolic needs of the cell by acting 
as a mode of cell signaling [40]. At lower levels of production, the presence of ROS may be 
beneficially used as a metabolic response to hypoxia by regulating the stability of HIF-1a. 
Medium levels of ROS production are more indicative of an inflammatory response by acti-
vating mitogen-activated protein kinase (MAPK) and proinflammatory cytokines. Excessive 
levels of ROS production, however, become pathological, and may lead to mitochondrial and 
cell apoptosis through activation of the apoptosome protein complex. Interaction of apoptosis 
activating factor (APAF-1) with mitochondrial cytochrome c plays in integral role in activa-
tion of the apoptosome, which will then lead to the activation of a chain of apoptotic caspases. 
The decision of whether the cell enters a state of inflammation or apoptosis, dictated by rela-
tive amount of mitochondrial ROS found within the cell, highlights the importance of ROS 
in choosing which cell signaling pathway will proceed. Overproduction of ROS is observed 
to be the cause of inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, and 
atherosclerosis by over-activating MAPKs [40].
This state of overproducing ROS may be stimulated by a multitude of enzymes. An example 
includes myeloperoxidase (MPO), a subfamily of peroxidases, due to its role in producing 
hypochlorous acid (HOCl) from hydrogen peroxide (H
2
O
2
) during an immune response. 
MPO’s, unique to neutrophils and monocytes, are active in respiratory burst, a cytotoxic 
mechanism to kill pathogens and bacteria. Excessive production of HOCl, however, may 
cause oxidative damage, apoptosis and inflammatory disease. The clinical significance of 
excessive ROS production through MPO can be seen in its role in the formation of nitrotyro-
sine in endothelial regions of inflammation, impairment of NO-dependent relaxation of blood 
vessels, and inactivation of select neutrophil granule contents during inflammation, which 
may then to a prolonged respiratory burst. These detriments are apparent in pathologies asso-
ciated with MPO defects, such as atherosclerosis and plaque formation, multiple sclerosis and 
Alzheimer’s disease [4].
When produced above basal levels necessary for cell signaling and transduction, the cell 
requires specific mechanism to eradicate ROS in order to return to physiological condi-
tions. The toxic effects of excessive mitochondrial ROS production necessitate that the cell 
has developed antioxidant mechanisms to scavenge them after generation. These mecha-
nisms to counteract ROS production include the use of the Superoxide Dismutase (SOD) 
family, which catalyze the initial reaction of O
2
—to hydrogen peroxide (H
2
O
2
), a product 
that will eventually reduce to water through glutathione peroxidase and catalase. The SOD 
family, found in three isoforms, can be found within the cell cytoplasm, mitochondria and 
nucleus. The isoform SOD2 exemplifies the detrimental effects of overproduction of ROS: 
the removal of mitochondrial SOD2 in species such as yeast, flies and mice is associated with 
cardiomyopathy, aging and early death, and atherosclerosis. The SOD2 gene codes for the 
protein Manganese SOD (MnSOD), and is found within the inner mitochondrial membrane 
and dismutates superoxide anions, produced by the mitochondrial electron transport chain, 
into H
2
O
2
. Overproduction or incomplete metabolism of these superoxide anions can cause 
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oxidative damage. The importance of MnSOD was reinforced in a study where knockout 
mice for SOD2 displayed increased mitochondrial oxidative damage and cell apoptosis. The 
mice deficient of MnSOD died within 1 week due to either dilated cardiomyopathy or neuro-
degeneration [11]. Deficiencies in other members of the SOD family did not demonstrate the 
same severity in oxidative damage as SOD2. Additionally, MnSOD and SOD2 play impera-
tive roles in the intrinsic pathway for apoptosis, through its involvement in mitochondrial 
permeability transition. Mitochondrial permeability transition utilizes mitochondrial cyto-
chrome c, APAF-1 and caspase 9 to ensure cell death, an outcome possible from excessive 
production of ROS [41].
In physiological conditions, the presence of the ROS superoxide can be quickly eradicated by 
the presence of these SODs; however, when synthesized in close proximity to NO, the toxic 
radical peroxynitrite (ONOO-) may be spontaneously formed. The reaction, which does not 
require an enzyme, may outcompete the scavenging capabilities of SOD [18]. Peroxynitrite, 
once formed, can cross cell membranes through both anion channels or passive diffusion 
and reacts selectively throughout the cell by nitrating tyrosine residues on proteins [17]. The 
presence of nitrotyrosines will alter the conformation and function of proteins such as neuro-
filaments and actin, leading to pathologies such as atherosclerosis, myocardial ischemia and 
irritable bowel syndrome [17]. Additionally, peroxynitrites can oxidize the heme groups of 
various proteins, including hemoglobin, myoglobin and cytochrome c [18]. By reacting in the 
same manner with inducible NOS, peroxynitrite can alter negative feedback of itself in inflam-
matory conditions. Peroxynitrite may also damage DNA through oxidation of bases and the 
DNA backbone, and contribute to apoptosis. During reperfusion or states of inflammation, 
the mitochondrion produces higher levels of NO. NO has the effect of inhibiting complex IV 
of the electron transport chain, increasing electron leakage, and consequently, the formation 
of superoxide. Therefore, the subsequent increase in peroxynitrite from NO and superoxide, 
can cause mitochondrial oxidative damage and increase the amount of free radicals present 
[18]. These elevated concentrations of peroxynitrite and superoxide are found in endothelium 
due to the uncoupling of endothelial NOS and vascular NADPH oxidase. In pathological 
conditions, due to excessive ROS production, NO is altered to become ONOO─, preventing 
endothelial-dependent relaxation, and causing endothelial dysfunction. The initial adverse 
event due to the decrease in NO bioavailability is impaired endothelium-dependent vasodi-
lation, which may spiral into long-term cardiovascular complications due to the decreased 
vasorelaxation. This dysfunction in vascular endothelium is then associated with pathologies 
ranging from hypertension, preeclampsia, and atherosclerosis to coronary artery disease [42].
The premise that inadequate scavenging of excessive ROS is detrimental to normal cellular 
function is reinforced by the existence of multiple antioxidant mechanisms, such as glutathi-
one peroxidase (GPx). Decreased efficiency of GPx, which catalyzes the reduction of H
2
O
2
 
to water using NADPH as a substrate, may lead to pathologies such as atherosclerosis and 
vascular inflammation [2]. Additionally, deficiencies in antioxidant enzymes such as perox-
iredoxin and mitochondrial thioredoxin 2 (Trx2) lead to mitochondrial apoptosis and vascular 
pathologies and myocardial infarction. Knocking out these imperative enzymes within mice 
models demonstrate that insufficient removal of ROS due to inefficient antioxidant mecha-
nisms will also lead to excessive ROS amounts and its damaging effects.
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Other proteins involved with the cellular response to stress and in physiological conditions 
include the family of heat shock proteins. Heat shock proteins (HSP’s), such as HSP70 and 
HSP27, are observed as stress-response proteins induced by ROS through the JAK-STAT path-
way [43]. In normal, physiological conditions, HSP’s serve as molecular chaperones required 
to prevent improper folding of proteins found within a cell. Their synthesis, however, is 
increased in response to environmental stresses in an attempt to prevent protein aggregation. 
Additionally, HSP’s are observed to be directly involved in the signaling pathways that lead 
a cell to undergo apoptosis in response to stress. For example, the overproduction of the reac-
tive oxygen species H
2
O
2
 activates the JAK-STAT pathway that leads to HSP70 production. 
The beneficial expression of HSP70 in response to ROS-induced stress was exemplified in the 
myocardium of transgenic mice [44]. Following a period of ischemia, the correction of meta-
bolic acidosis and re-establishment of correct phosphate stores due to the presence of HSP70 
exemplify its protective effects against cardiomyopathy. Likewise, the reduction of expres-
sion of heat shock protein 27 inhibits the regulation ROS-induced apoptosis in cardiomyo-
cytes [45]. This observation is exemplified by the overproduction of Hsp27 in the rat cardiac 
cell line H92c in comparison to a control, and the consequent suppression of H
2
O
2
-induced 
injury and apoptosis and the protective increase in phosphatidylinositol 3-kinase (PI3K)—
protein kinase B(Akt) pathway activation when plentiful amounts of Hsp27 are present [45]. 
Both Hsp70 and Hsp27 serve to demonstrate the integral role of heat shock proteins in both 
physiological conditions and stressful conditions such as ROS-induced oxidative stress.
The impact of the presence of excessive ROS may also be found in its role in protein post-trans-
lational modification, in both irreversible or reversible protein oxidative modifications. The 
interaction between ROS, reactive nitrogen species (RNS), and amino acid residues has been 
observed to lead to aging and protein dysfunction. Commonly, these post-translational modi-
fications occur most readily on the thiol (─SH) functional group found on cysteine residues: 
the electron rich sulfur atom within the thiol group allows for the oxidization a cysteine to 
sulfenic, sulfinic or sulfonic acid in addition to other oxidative posttranslational modifications 
(Ox-PTM) such as nitrosylation, sulfhydration, glutathionylation, and sulfenylation [46]. When 
ROS/RNS react with the thiol through nitrosylation, studies have found the reaction serves a 
function for cardioprotection [47]. More specifically, nitrosylation of cysteine residues acts as a 
barrier during periods of oxidative stress against further modification and oxidative damage, 
and may therefore lead to a faster recovery time [47]. ROS/RNS reactions with the thiol through 
glutathionylation as a reversible Ox-PTM have been previously linked with neurodegenerative 
and cardiovascular disease. ROS also have the ability to form thiyl radicals (RS.) to react with 
thiolates and form disulfide bonds, causing static protein conformations. The formation of disul-
fide bonds can alter the geography of the protein, and change the conformation and therefore 
function of the protein itself. Sulfenylation, a highly reactive and unstable form of modification 
has been associated with irreversible oxidative damage and apoptosis of a cell. Other modifica-
tions can include carbonylation, and phosphorylation [48]. These modifications may alter the 
polarity of the amino acid, ultimately modulating cell signal transduction and its downstream 
effects. In addition, the modifications may alter metal cofactor interaction and may inadver-
tently affect inhibitor reactions and impact physiological and drug reactions. A common effect 
of protein carbonylation, specifically, may be protein inactivation; the inactivation of membrane 
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transporters such as glucose (GLUT) transporters and Na+-K+ ATPases may lead to a multitude 
of neurodegenerative disorders. Additionally, oxidation of residues such as methionine to a sulf-
oxide may occur as well, which may serve to decrease cell signaling, and cause phosphorylation 
[49]. The inactivation of important antioxidant mechanisms such as glutathione peroxidase and 
thioredoxin due to protein modification may occur and act to aggravate oxidative stress within 
a cell. Other modifications may induce the phosphorylation of HSP27 in an attempt to prevent 
the unfolding and degradation of imperative proteins necessary for cell metabolism [45]. The 
fluctuations in ROS production, which distinguishes physiological metabolism from pathologi-
cal metabolism, is revealed through the relative amount of Ox-PTM of critical cysteine thiols due 
to its role in regulation of oxidative stimuli.
The amount of mitochondrial ROS ranging from lower, basal physiological levels to excessive 
pathological levels highlights the importance of ROS and its maintenance. Excessive ROS pro-
duction or inadequate scavenging by the cell’s antioxidant mechanisms may cause a multitude 
of complications within a cell, leading to mitochondrial oxidative damage or cell apoptosis. 
The overproduction of ROS by MPO demonstrates how excessive amounts of HOCl may lead 
to pathologies such as atherosclerosis, while deficiencies in SOD2/MnSOD, GPx, peroredoxin, 
and Trx2 demonstrate how inadequate scavenging may lead to vascular and inflammatory 
complications as well. The role of HSP’s to prevent protein aggregation caused by ROS accu-
mulation underscores the importance of cell signal transduction pathways in response to exces-
sive ROS. The detrimental outcomes of high levels of ROS can be seen through the multitude of 
effects due to oxidative protein post-translational modifications. ROS, both good and bad, can 
widely affect the intricate network of a variety of distinct proteins found within a single cell.
5. Conclusions and gaps
We hope the readers understand the there are two sides to reactive oxygen species—a “good 
side” and a “bad side.” We opine that if one reads the literature, ROS are equated with pathol-
ogy, and adverse consequences. Our goal is this chapter was to reinforce the concept that 
these species have many important physiological actions. The largest gap we see in our under-
standing of ROS and their actions pertains to defining the boundaries of the redox window. 
This will be important to study and understanding since the boundary marks the transition of 
ROS from being beneficial to being detrimental.
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